These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 10520880)
41. Efficacy of 1-week ranitidine-bismuth-citrate (RBC)-based triple therapy for eradication of Helicobacter pylori infection. Savarino V; Vigneri S Aliment Pharmacol Ther; 1999 Sep; 13(9):1251-2. PubMed ID: 10468709 [No Abstract] [Full Text] [Related]
42. [Reconsider management of Helicobacter pylori infections. Time to go over to the triple therapy]. Jaup BH Lakartidningen; 1996 Feb; 93(9):800-1. PubMed ID: 8656895 [No Abstract] [Full Text] [Related]
45. [Treatment of Helicobacter pylori infection]. van der Hulst RW; Keller JJ; Rauws EA; Tytgat GN Ned Tijdschr Geneeskd; 1996 May; 140(18):967-70. PubMed ID: 8692312 [No Abstract] [Full Text] [Related]
46. Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension. Migneco A; Ojetti V; Specchia L; Franceschi F; Candelli M; Mettimano M; Montebelli R; Savi L; Gasbarrini G Helicobacter; 2003 Dec; 8(6):585-9. PubMed ID: 14632672 [TBL] [Abstract][Full Text] [Related]
47. Double-liposome-based dual-drug delivery system as vectors for effective management of peptic ulcer. Jain AK; Agarwal A; Agrawal H; Agrawal GP J Liposome Res; 2012 Sep; 22(3):205-14. PubMed ID: 22889385 [TBL] [Abstract][Full Text] [Related]
48. Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection: a review. Gisbert JP; Pajares JM; Valle J Helicobacter; 1999 Mar; 4(1):58-66. PubMed ID: 10352089 [No Abstract] [Full Text] [Related]
49. The treatment of Helicobacter pylori infection. Pounder RE; Williams MP Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():35-41. PubMed ID: 9146789 [TBL] [Abstract][Full Text] [Related]
50. [Intensifying the study of the proper treatment of digestive ulceration]. Yao X Zhonghua Nei Ke Za Zhi; 1997 Apr; 36(4):221-2. PubMed ID: 10374279 [No Abstract] [Full Text] [Related]
51. In vitro synergy between ranitidine bismuth citrate and tetracycline or clarithromycin against resistant strains of Helicobacter pylori. Midolo PD; Lambert JR; Kerr TG; Tee W Eur J Clin Microbiol Infect Dis; 1999 Nov; 18(11):832-4. PubMed ID: 10614963 [No Abstract] [Full Text] [Related]
52. H. pylori treatment recognized by FDA. Am J Health Syst Pharm; 1996 Jun; 53(11):1229. PubMed ID: 8725200 [No Abstract] [Full Text] [Related]
53. [Epidemiological research of Helicobacter pylori resistance to clarithromycin at inhabitants of Sankt of Petersburg with a stomach ulcer]. Baryshnikova NV; Denisova EV; Kornienko EA; Lobach SM; Loeva IA; Parolova NI; Ryzhikh VA; Solonitsin EG; Smirnova AS; Starostin BD; Suvorov AN; Suvorova MA; Tkachenko EI; Uspenskiĭ IuP Eksp Klin Gastroenterol; 2009; (5):73-6. PubMed ID: 20201309 [No Abstract] [Full Text] [Related]
55. Distribution of bismuth in the rat after oral dosing with ranitidine bismuth citrate and bismuth subcitrate. Canena J; Reis J; Pinto AS; Santos AM; Leitão J; Pinheiro T; Quina MG J Pharm Pharmacol; 1998 Mar; 50(3):279-83. PubMed ID: 9600719 [TBL] [Abstract][Full Text] [Related]
56. Helicobacter pylori eradication and weight gain: has it opened a Pandora's box? Chacko Y; Holtmann GJ Aliment Pharmacol Ther; 2011 Jul; 34(2):256. PubMed ID: 21679208 [No Abstract] [Full Text] [Related]
57. Bifunctional capsular dosage form: novel fanicular cylindrical gastroretentive system of clarithromycin and immediate release granules of ranitidine HCl for simultaneous delivery. Rajput P; Singh D; Pathak K Int J Pharm; 2014 Jan; 461(1-2):310-21. PubMed ID: 24309435 [TBL] [Abstract][Full Text] [Related]